Viatris
Dymista® Control
Dymista® Control is the first Pharmacy-only (P) nasal spray in the UK that contains a combination of an antihistamine and a corticosteroid.
It is indicated to relieve symptoms of moderate to severe seasonal allergic rhinitis (AR), or hay fever, in adults if monotherapy with either intranasal antihistamine or corticosteroid is not considered sufficient.
To help ensure pharmacists and their teams are equipped with the knowledge and expertise to answer customer queries and appropriately supply Dymista® Control, we created a compelling yet comprehensive video module to educate on all aspects of the product, including category, indication, contraindications and red flags, alongside patient scenarios and interactive elements to help learner’s put their knowledge into practice in the pharmacy.
In tandem, we produced a bite-sized printed Quick Guide that was distributed via our market-leading magazines to every UK pharmacy, and also acted as an aid for the field sales force.
In addition to creating and disseminating the training we also designed the Pharmacy Essential Guide (Risk Management Material) and distributed it to all UK Pharmacies.
News
Contact
All content copyright CIG Healthcare Partnership © 2025
Website designed and built by CIG Creative